Botulinum Toxin Type A 相關新聞

← 返回新聞總覽


Botulinum Toxin Type A 目前有 1 則相關新聞報導,預測適應症 20 個。

本頁整合 Botulinum Toxin Type A 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown (glabellar lines), when the severity of the above facial lines has an important...
  • 證據等級:L5
  • 預測適應症(20 個):
    • primary hereditary glaucoma(89.4%)
    • parkinsonian disorder(88.8%)
    • open-angle glaucoma(88.8%)
    • insomnia (disease)(87.5%)
    • glaucoma 1, open angle(79.0%)
    • restless legs syndrome(77.9%)
    • Parkinson disease(77.7%)
    • paralysis agitans, juvenile, of Hunt(77.3%)
    • bronchitis(75.8%)
    • autosomal recessive Parkinson disease(73.3%)
    • lethal infantile mitochondrial myopathy(73.1%)
    • enterocolitis (disease)(73.0%)
    • glaucoma(72.8%)
    • irritable bowel syndrome(72.7%)
    • open angle glaucoma(72.0%)
    • progressive supranuclear palsy-corticobasal syndrome(71.5%)
    • anxiety(70.3%)
    • headache disorder(70.2%)
    • sleep disorder, initiating and maintaining sleep(69.2%)
    • trigeminal autonomic cephalalgia(69.1%)

查看完整藥物報告 →

相關新聞(1 則)

Aktualisierte S2k-Leitlinie COPD 2026: Individualisierte Pharmakotherapie im Fokus - Gelbe Liste

2026-04-27 copd

來源:Gelbe Liste


免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.